203Pb/212Pb-radiolabled ErbB-2 receptor targeting peptides (AlphaMed)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name203Pb/212Pb-radiolabled ErbB-2 receptor targeting peptides (AlphaMed)
Drug Alias NameN/A
ClassificationSmall moleculesRadiation-emitting products
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 modulators
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlphaMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlphaMed Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A